As of May 2024 BioLineRx has a market cap of $52.76 Million. This makes BioLineRx the world's 7736th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $52.76 M | -51.65% |
2023 | $0.10 B | 197.66% |
2022 | $36.66 M | -63.13% |
2021 | $99.42 M | 66.18% |
2020 | $59.83 M | 124.85% |
2019 | $26.6 M | -46.6% |
2018 | $49.83 M | -56.49% |
2017 | $0.11 B | 124.67% |
2016 | $50.98 M | -29.04% |
2015 | $71.84 M | 11.06% |
2014 | $64.69 M | -5% |
2013 | $68.09 M | 47.16% |
2012 | $46.27 M | 18.1% |
2011 | $39.18 M |
On May 2nd, 2024 the market cap of BioLineRx was reported to be: